THIS CHANGES EVERYTHING
The BIOFIRE® SPOTFIRE®
Respiratory Solution
bioMérieux is pleased to announce a revolutionary portfolio of versatile, lab-grade respiratory PCR tests, the targeted BIOFIRE® SPOTFIRE® Respiratory (R) Panel Mini and expanded BIOFIRE® SPOTFIRE® Respiratory (R) Panel, which give clinicians flexible syndromic options as they care for a variety of patients. These tests run on a new, fast, easy-to-use BIOFIRE® SPOTFIRE® System.
©2023 bioMérieux, Inc. • BIOMÉRIEUX, the BIOMÉRIEUX logo, PIONEERING DIAGNOSTICS, BIOFIRE, and FILMARRAY are used pending and/or registered trademarks belonging to bioMérieux, or one of its subsidiaries, or one of its companies • Patents • 515 Colorow Drive, Salt Lake City, UT 84108 • Tel: (800) 634-7656
bioMérieux S.A. • 69280 Marcy l’Etoile • France • www.biomerieux-usa.com
Please fill out the form below to receive updates on the new SPOTFIRE solution:
By clicking the button below, you have read and agree to the Privacy Policy and agree to receive emails from bioMérieux. You can unsubscribe at any time.
* Required Fields
The SPOTFIRE System is designed to run the SPOTFIRE R Panels.
Sample Type: Nasopharyngeal swab in viral transport media
Hands-on time: 1-2 minutes
Overall Performance:1 PPA: 98.7% NPA: 98.4%
SARS-CoV-2 Performance:1 PPA: 97.3%, NPA: 99.4%
VIRUSES:
The typical symptoms of a respiratory infection can be caused by many viruses and bacteria. Remove the guesswork with syndromic testing.
Sample Type: Nasopharyngeal swab in viral transport media
Hands-on time: 1-2 minutes
Overall Performance:1 PPA: 98.5% NPA: 99.1%
SARS-CoV-2 Performance:1 PPA: 97.3%, NPA: 99.4%
VIRUSES:
BACTERIA: